Viewing Study NCT01126892


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2025-12-25 @ 6:38 PM
Study NCT ID: NCT01126892
Status: COMPLETED
Last Update Posted: 2017-02-28
First Post: 2010-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module